short chain fatty acids

  1. Sly Saint

    Microbial community-scale metabolic modelling predicts personalized short-chain fatty acid production profiles in the human gut 2024

    Abstract Microbially derived short-chain fatty acids (SCFAs) in the human gut are tightly coupled to host metabolism, immune regulation and integrity of the intestinal epithelium. However, the production of SCFAs can vary widely between individuals consuming the same diet, with lower levels...
  2. Andy

    Effects of short-chain fatty acids on intestinal function in an enteroid model of hypoxia 2022 Pearce et al

    The healthy GI tract is physiologically hypoxic, but this may be perturbed by certain acute and chronic stressors that reduce oxygen availability systemically. Short-chain fatty acids have been shown to have beneficial effects on intestinal barrier function and inflammation. Therefore, our...
  3. Andy

    Short-chain fatty acids are key mediators of the favorable effects of the Mediterranean diet on intestinal barrier integrity, 2022, Seethaler et al

    ABSTRACT Background The Mediterranean diet is associated with the prevention of diabetes, cardiovascular disease, and cancer, all of which are linked to intestinal barrier impairment. Objectives Here, we hypothesize that the Mediterranean diet, possibly via the induction of short-chain fatty...
  4. Andy

    Regulation of CD4+ and CD8+ T Cell Biology by Short-Chain Fatty Acids and Its Relevance for Autoimmune Pathology, 2022, Schiweck et al

    Abstract The gut microbiota encodes a broad range of enzymes capable of synthetizing various metabolites, some of which are still uncharacterized. One well-known class of microbiota-derived metabolites are the short-chain fatty acids (SCFAs) such as acetate, propionate, butyrate and valerate...
  5. Andy

    Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases, 2022, Hu et al

    Highlights • Short chain fatty acids metabolism in the body was clarified. • Multiple effects of various SCFAs in a variety of cardiovascular diseases. • The underlying pathophysiological mechanism for cardiovascular effects of individual SCFAs. Abstract Cardiovascular diseases (CVDs) are the...
  6. Andy

    Real-Time Non-Invasive Monitoring of Short-Chain Fatty Acids in Exhaled Breath, 2022, Meurs et al

    Short-chain fatty acids (SCFAs) are important metabolites produced by the gut microbiome as a result of the fermentation of non-digestible polysaccharides. The most abundant SCFAs are acetic acid, propionic acid, and butyric acid which make up 95% of this group of metabolites in the gut. Whilst...
  7. Midnattsol

    Bistability in fatty-acid oxidation resulting from substrate inhibition, 2021, Bakker et al

    Abstract In this study we demonstrated through analytic considerations and numerical studies that the mitochondrial fatty-acid β-oxidation can exhibit bistable-hysteresis behavior. In an experimentally validated computational model we identified a specific region in the parameter space in which...
  8. Andy

    Gut-derived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation, 2022, Trompette et al

    Abstract Barrier integrity is central to the maintenance of healthy immunological homeostasis. Impaired skin barrier function is linked with enhanced allergen sensitization and the development of diseases such as atopic dermatitis (AD), which can precede the development of other allergic...
  9. Andy

    Microbial lactate utilisation and the stability of the gut microbiome, 2022, Louis et al

    Abstract The human large intestinal microbiota thrives on dietary carbohydrates that are converted to a range of fermentation products. Short-chain fatty acids (acetate, propionate and butyrate) are the dominant fermentation acids that accumulate to high concentrations in the colon and they...
  10. Andy

    Inter-species Metabolic Interactions in an In-vitro Minimal Human Gut Microbiome of Core Bacteria, 2022, Shetty et al

    Abstract Knowledge of the functional roles and interspecies interactions are crucial for improving our understanding of the human intestinal microbiome in health and disease. However, the complexity of the human intestinal microbiome and technical challenges in investigating it pose major...
  11. Andy

    Hypoxia Improves Endurance Performance by Enhancing Short Chain Fatty Acids Production via Gut Microbiota Remodeling, 2022, Huang et al

    Hypoxia environment has been widely used to promote exercise capacity. However, the underlying mechanisms still need to be further elucidated. In this study, mice were exposed to the normoxia environment (21% O2) or hypoxia environment (16.4% O2) for 4 weeks. Hypoxia-induced gut microbiota...
  12. Andy

    AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms, 2022, Maëva et al

    ABSTRACT Alterations in brain/gut/microbiota axis are linked to Irritable Bowel Syndrome (IBS) physiopathology. Upon gastrointestinal infection, chronic abdominal pain and anxio-depressive comorbidities may persist despite pathogen clearance leading to Post-Infectious IBS (PI-IBS). This study...
  13. Andy

    The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS), 2022, Scheibenbogen et al

    Myalgic encephalomyelitis (ME) or Chronic Fatigue Syndrome (CFS) is a neglected, debilitating multi-systemic disease without diagnostic marker or therapy. Despite evidence for neurological, immunological, infectious, muscular and endocrine pathophysiological abnormalities, the etiology and a...
  14. Andy

    Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Parkinson Disease Patients, 2022, Chen

    Abstract Background and Objectives: Short-chain fatty acids (SCFAs) are gut microbial metabolites that promote the disease process in a rodent model of Parkinson’s disease (PD), but fecal levels of SCFAs in PD patients are reduced. Simultaneous assessments of fecal and plasma SCFA levels, and...
  15. Andy

    Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss, 2018, Zaiss et al

    Open access at https://www.nature.com/articles/s41467-017-02490-4 Article based on study - https://www.fau.eu/2018/01/12/news/research/can-muesli-help-against-arthritis/
Back
Top Bottom